Parkinson’s Research News

Newsfeed:

  • Could this newly discovered protein help treat Parkinson’s?
    Researchers have identified a protein that could reduce toxic aggregations in the brain. Their finding could lead to new therapies for Parkinson's disease. ... read more
    Source: Medical News DailyPublished on 2019-07-03
  • Active sexual life may benefit men with early Parkinson’s disease
    (Wiley) New research published in the European Journal of Neurology indicates that an active sexual life is linked with lower disability and better quality of life in men with early Parkinson's disease. ... read more
    Source: Eureka AlertPublished on 2019-07-03
  • Guten tag! MODAG
      Last week the German biotech firm MODAG announced that they had secure €12M in series A funding from various venture capital investors. The company is going to use those funds to clinically develop their lead compound – Anle138b – in the neurodegenerative condition, Multiple ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-07-02By Simon
  • Dundee partners with Bukwang Pharm to develop new treatment for Parkinson’s
    (University of Dundee) A multi-million pound partnership will see the University of Dundee partner with the Korean company Bukwang Pharm to develop new drug targets for Parkinson's Disease. The work will see researchers develop drug-like molecules that target an enzyme known to play a role in the progression of the disease. ... read more
    Source: Eureka AlertPublished on 2019-07-02
  • Sense of smell, pollution and neurological disease connection explored
    Damaged olfactory neurons as a result of air pollution may contribute to altered cerebrospinal fluid flow and turnover, acting as a potential mechanism for the development of neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-07-01By Neuroscience News
  • Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s
    (Parkinson's UK) Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition. ... read more
    Source: Eureka AlertPublished on 2019-07-01
  • Sense of smell, pollution and neurological disease connection explored
    (Penn State) A consensus is building that air pollution can cause neurological diseases such as Alzheimer's disease and Parkinson's disease, but how fine, sooty particles cause problems in the brain is still an unanswered question. Now a team of Penn State researchers, using mice, have found a possible way, but more research is still needed. ... read more
    Source: Eureka AlertPublished on 2019-07-01
  • Monthly Research Review – June 2019
      At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during June 2019. The post is divided into seven parts based on the type of research: ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-06-30By Simon
  • Moments of clarity in dementia patients at end of life: Glimmers of hope?
    Paradoxical lucidity, the phenomenon where some with severe dementia suddenly regain their memory and exhibit normal behaviors immediately prior to death, may help shed new light on the mechanisms of Alzheimer's disease. ... read more
    Source: Neuro Science NewsPublished on 2019-06-29By Neuroscience News
  • Dementia study links gene with damage to brain connections
    Post mortem examinations of brain tissue from Alzheimer's patients revealed synapses contained clumps of clusterin, in addition to amyloid beta. The clumps were more abundant in those with genetic risk factors from Alzheimer's disease. ... read more
    Source: Neuro Science NewsPublished on 2019-06-27By Neuroscience News
  • New mouse model of Parkinson’s disease shows how it spreads from the gut
    Parkinson's disease can begin in the gut and spread to the brain via the vagus nerve, researchers report. This pathway was observed in a new mouse model, which recapitulates both motor and non-motor deficits as well as early-stage and late-stage features associated with Parkinson's disease. ... read more
    Source: Science DailyPublished on 2019-06-26
  • Neuronal Parkinson inclusions are different than expected
    An international team of researchers challenges the conventional understanding of the cause of Parkinson's disease. The researchers have shown that the inclusions in the brain's neurons, characteristic of Parkinson's disease, are comprised of a membranous medley rather than protein fibrils. ... read more
    Source: Science DailyPublished on 2019-06-26
  • New research shows Parkinson’s disease origins in the gut
    A new study adds to the growing body of evidence that Parkinson's disease may start in the gut. Researchers found gut-to-brain propagation of alpha-synuclein spread via the vagus nerve. The study provides a more accurate model of Parkinson's progression and could lead to new treatments to halt or prevent this neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-06-26By Neuroscience News
  • Scientists track Parkinson’s journey from gut to brain in mice
    In a mouse model of Parkinson's disease, scientists can now track the journey of toxic protein from the gut to the brain via the vagus nerve. ... read more
    Source: Medical News DailyPublished on 2019-06-26
  • New contents: Neuronal Parkinson inclusions are different than expected
    (University of Basel) An international team of researchers involving members of the University of Basel's Biozentrum challenges the conventional understanding of the cause of Parkinson's disease. The researchers have shown that the inclusions in the brain's neurons, characteristic of Parkinson's disease, are comprised of a membranous medley rather than protein fibrils. The recently published study in 'Nature Neuroscience' raises new ... read more
    Source: Eureka AlertPublished on 2019-06-26
  • These common drugs may increase dementia risk
    Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half. ... read more
    Source: Medical News DailyPublished on 2019-06-25
  • Commonly prescribed drugs could increase the risk of dementia
    Anticholinergic drugs, commonly prescribed to treat a range of disorders, from Parkinson's disease to bladder conditions, may increase dementia risks. The increased risk was linked to anticholinergic antidepressants, antipsychotics, bladder control, epilepsy and Parkinson's disease medications. There were no increased risks associated with other types of anticholinergics, such as gastrointestinal drugs or antihistamines. ... read more
    Source: Neuro Science NewsPublished on 2019-06-24By Neuroscience News
  • Physical evidence in the brain for types of schizophrenia
    Post-mortem examination of 42 brain tissue samples of people with schizophrenia revealed a buildup of abnormal proteins similar to that found in people with neurodegenerative diseases. Many of the abnormal proteins were involved in nervous system development, specifically neurogenesis. ... read more
    Source: Neuro Science NewsPublished on 2019-06-24By Neuroscience News
  • Certain cells secrete a substance in the brain that protects neurons
    Researchers have discovered a secret sauce in the brain's vascular system that preserves the neurons needed to keep dementia and other diseases at bay. ... read more
    Source: Science DailyPublished on 2019-06-24
  • Squeezing of blood vessels may contribute to cognitive decline in Alzheimer’s
    Capillary constriction caused by amyloid beta restricts cerebral blood flow in mouse models of Alzheimer's disease. Inhibiting the capillary constriction may potentially reduce some of the neurodegenerative features of Alzheimer's. ... read more
    Source: Neuro Science NewsPublished on 2019-06-23By Neuroscience News
  • Gut bacteria can alter how well a medication works
    New research uses the example of a Parkinson's disease drug to show how gut bacteria can influence the efficacy of certain medications. ... read more
    Source: Medical News DailyPublished on 2019-06-22
  • Dream, struggle, create, Prevail
      The recent documents filed with the U.S. Securities and Exchange Commission by the biotech firm Prevail Therapeutics provides interesting insight into the bold plans of this company which was only founded in 2017. Even more recent news that the U.S. Food and Drug Administration (FDA) has ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-06-21By Simon
  • A new drug target for chemically induced Parkinson’s disease
    Mitochondrial CYP2D6 may be a powerful target for the treatment of Parkinson's disease induced by MPTP. ... read more
    Source: Neuro Science NewsPublished on 2019-06-21By Neuroscience News
  • A new drug target for chemically induced Parkinson’s disease
    An enzyme that modifies chemicals formed in the body by alcohol, tobacco, and certain foods may be a new target for treating Parkinson's disease. The altered compounds, the researchers found, may play a role in triggering the onset or advancing the progression of the neurodegenerative condition. ... read more
    Source: Science DailyPublished on 2019-06-21
  • A new drug target for chemically induced Parkinson’s disease
    (University of Pennsylvania) An enzyme that modifies chemicals formed in the body by alcohol, tobacco, and certain foods may be a new target for treating Parkinson's disease, according to a team led by University of Pennsylvania scientists. The altered compounds, the researchers found, may play a role in triggering the onset or advancing the progression of the neurodegenerative condition. ... read more
    Source: Eureka AlertPublished on 2019-06-21
1 2 3 4 5 64